These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11562290)

  • 21. Antibacterial drug discovery--then, now and the genomics future.
    Monaghan RL; Barrett JF
    Biochem Pharmacol; 2006 Mar; 71(7):901-9. PubMed ID: 16494849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomics of host-pathogen interactions.
    Schnappinger D
    Prog Drug Res; 2007; 64():311, 313-43. PubMed ID: 17195480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional gene discovery using RNA interference-based genomic screens to combat pathogen infection.
    Hong-Geller E; Micheva-Viteva SN
    Curr Drug Discov Technol; 2010 Jun; 7(2):86-94. PubMed ID: 20836760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome comparisons as a tool for antimicrobial target discovery.
    Sun H; Chen HF; Chen R
    Methods Mol Biol; 2013; 993():31-8. PubMed ID: 23568462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel targets for the future development of antibacterial agents.
    McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
    Symp Ser Soc Appl Microbiol; 2002; (31):28S-34S. PubMed ID: 12481826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of genomics to select antibacterial targets.
    Pucci MJ
    Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural proteomics: the potential of high-throughput structure determination.
    Schmid MB
    Trends Microbiol; 2002; 10(10 Suppl):S27-31. PubMed ID: 12377565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using bacterial genomes and essential genes for the development of new antibiotics.
    Fields FR; Lee SW; McConnell MJ
    Biochem Pharmacol; 2017 Jun; 134():74-86. PubMed ID: 27940263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
    Uddin R; Sufian M
    PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural genomics of highly conserved microbial genes of unknown function in search of new antibacterial targets.
    Abergel C; Coutard B; Byrne D; Chenivesse S; Claude JB; Deregnaucourt C; Fricaux T; Gianesini-Boutreux C; Jeudy S; Lebrun R; Maza C; Notredame C; Poirot O; Suhre K; Varagnol M; Claverie JM
    J Struct Funct Genomics; 2003; 4(2-3):141-57. PubMed ID: 14649299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial genomics: potential for antimicrobial drug discovery.
    Fritz B; Raczniak GA
    BioDrugs; 2002; 16(5):331-7. PubMed ID: 12408737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Will genomics revolutionise pharmaceutical R&D?
    Noble D
    Trends Biotechnol; 2003 Aug; 21(8):333-7. PubMed ID: 12902169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel genomic methods for drug discovery and mechanism-based toxicological assessment.
    Gant TW; Zhang SD; Taylor EL
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):72-80. PubMed ID: 19152215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivering novel targets and antibiotics from genomics.
    Payne DJ; Holmes DJ; Rosenberg M
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1028-34. PubMed ID: 11892909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in functional genomics approaches to antifungal drug target discovery.
    De Backer MD; Van Dijck P
    Trends Microbiol; 2003 Oct; 11(10):470-8. PubMed ID: 14557030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of novel biomedicine based on genome science.
    Baba Y
    Eur J Pharm Sci; 2001 Apr; 13(1):3-4. PubMed ID: 11292562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic
    Shaik S; Ranjan A; Tiwari SK; Hussain A; Nandanwar N; Kumar N; Jadhav S; Semmler T; Baddam R; Islam MA; Alam M; Wieler LH; Watanabe H; Ahmed N
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066550
    [No Abstract]   [Full Text] [Related]  

  • 38. Ten years of bacterial genome sequencing: comparative-genomics-based discoveries.
    Binnewies TT; Motro Y; Hallin PF; Lund O; Dunn D; La T; Hampson DJ; Bellgard M; Wassenaar TM; Ussery DW
    Funct Integr Genomics; 2006 Jul; 6(3):165-85. PubMed ID: 16773396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptide ligands in antibacterial drug discovery: use as inhibitors in target validation and target-based screening.
    Lapan KA; Chapple JP; Galcheva-Gargova Z; Yang M; Tao J
    Expert Opin Ther Targets; 2002 Aug; 6(4):507-16. PubMed ID: 12223065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways.
    Gerdes SY; Scholle MD; D'Souza M; Bernal A; Baev MV; Farrell M; Kurnasov OV; Daugherty MD; Mseeh F; Polanuyer BM; Campbell JW; Anantha S; Shatalin KY; Chowdhury SA; Fonstein MY; Osterman AL
    J Bacteriol; 2002 Aug; 184(16):4555-72. PubMed ID: 12142426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.